Digbi Health Incorporates Ethnic-Relevant Genetic Risk Scores to Personalize Care for Metabolic and Mental Health Conditions Associated With Gut and Obesity
Care is personalized using the member's ethnic ancestry as measured by their DNA sequence, gut microbiome, food habits and food preferences.
MOUNTAIN VIEW, Calif., January 17, 2022 /Digbi Newswire/ -- Digbi Health today announced it is incorporating ethnic-specific risk scores for nutrition, fitness, obesity, diabetes, hypertension, and mental and digestive health across its virtual care program for people living with polychronic physical and mental illness associated with inflammatory gut and weight.
Addressing health outcome inequities
Digbi's new genetic scores address health outcome inequities. Care is personalized using the member's ethnic ancestry, measured by their DNA sequence, gut microbiome, food habits and food preferences.
In a published study of 393 adults, Digbi's polychronic care program proved to be equally effective across ethnicities and income levels.
Why one population is not enough
It's extremely problematic for the health of an increasingly diverse workforce to limit genetic and gut microbiome data to one population, and to one-size-fits-all digital care programs that have proven bias towards one gender and ethnicity. Digbi's science and care team is committed to eliminating health outcome disparities while advancing our understanding of genetic and gut microbiome science.
— Ranjan Sinha, Founder and Chief Executive Officer, Digbi Health
Originally distributed via PR Newswire.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Health Equity
- Genetics
- Gut Microbiome
- Obesity
- Precision Biology